Basilea Pharmaceutica AG Allschwil (PK5) Stock Price & News

Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia

About Basilea Pharmaceutica AG Allschwil

CEODavid Veitch

Employees200

Founded2000

Headquarters-

SectorBiotechnology

Websitebasilea.com

All values in CHF	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	64.21M	64.21M	59.50M	59.50M
Cost of goods sold	41.35M	41.35M	34.73M	34.73M
Cost of revenue	41.35M	41.35M	34.73M	34.73M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.93M	8.93M	8.77M	8.77M
Operating expense	8.93M	8.93M	8.77M	8.77M
Total operating expenses	50.28M	50.28M	43.49M	43.49M
Operating income	13.93M	13.93M	16.00M	16.00M
Other non operating income	-309.00K	-309.00K	564.00K	564.00K
EBT including unusual items	13.26M	13.26M	16.07M	16.07M
EBT excluding unusual items	13.26M	13.26M	16.17M	16.17M
Income tax expense	1.05M	1.05M	2.10M	2.10M
Effective tax rate	7.89%	7.89%	13.07%	13.07%
Other operating expenses	-	-	-	-
Net income	12.22M	12.22M	13.97M	13.97M
Net profit margin	19.03%	19.03%	23.48%	23.48%
Earnings per share	-	-	-	-
Interest and investment income	357.50K	357.50K	308.50K	308.50K
Interest expense	-716.50K	-716.50K	-704.00K	-704.00K
Net interest expenses	-359.00K	-359.00K	-395.50K	-395.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	14.91M	14.91M	16.05M	16.05M
Gain or loss from assets sale	-	-	-	-

Ask anything